Federal Contractor Profile
Spark Therapeutics INC.
Federal contracting record: $649M obligated across 675 awards from 6 agencies, FY 2016–2026.
Company Profile
Parent UEI (Unique Entity Identifier)
MBQHAJK89D48
CAGE Code
53VP4
Registered Entities (UEIs)
5 under this organization
Address
1 DNA WAY, SOUTH SAN FRANCISCO, CA, 940804918
First Federal Award
Oct 5, 2015
Most Recent Award
Sep 1, 2026
Federal Sales Analytics
Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.
Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).
Top Federal Agencies
- Department of Health and Human Services$426M
65.7% of total obligations
- Department of Veterans Affairs$164M
25.2% of total obligations
- Department of Defense$57M
8.8% of total obligations
- Department of Justice$1.5M
0.2% of total obligations
- Department of Agriculture$194K
0.0% of total obligations
- Department of Homeland Security$0
0.0% of total obligations
Top NAICS Activity
- $253M
- $222M
- $158M
- $14M
- $2.6M
- $130K
- $108K
- $63K
- $54K
- $40K
Recent Federal Awards
| Date | Agency | NAICS | Description | Amount |
|---|---|---|---|---|
| Aug 28, 2026 | Department of Health and Human ServicesPHOENIX AREA INDIAN HEALTH SVC | 325413 | BPA CALL - ROCHE DIABETES CARE, SUPPLIES, PIMC, MATERIALS MANAGEMENT, POP: 09/27/2026 - 09/26/2027 | $250K → |
| Jul 29, 2026 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541714 | ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA | $8.0M |
| May 14, 2026 | Department of Veterans Affairs250-NETWORK CONTRACT OFFICE 10 (36C250) | 621511 | IGF:CT:IGF:TESTING | $237K |
| May 13, 2026 | Department of DefenseDLA TROOP SUPPORT | 325412 | 4571907151!TAMIFLU 75 MG CAPSULE 10S | $3K |
| May 11, 2026 | Department of DefenseDLA TROOP SUPPORT | 325412 | 8512097379!OTHER MEDICAL | $912K |
| Feb 10, 2026 | Department of Health and Human ServicesNAVAJO AREA INDIAN HEALTH SVC | 325413 | FY 25 ROCHE DIABETES CARE BPA - MEDICAL SUPPLY | $40K |
| Feb 9, 2026 | Department of Health and Human ServicesNAVAJO AREA INDIAN HEALTH SVC | 325413 | FY 25 ROCHE DIABETES CARE BPA - MEDICAL SUPPLY | $102K |
| Dec 8, 2025 | Department of DefenseDLA TROOP SUPPORT | 325412 | 4570295090!TAMIFLU 75 MG CAPSULE 10S | $1K |
| Sep 29, 2025 | Department of Veterans AffairsSTRATEGIC ACQUISITION CENTER FREDERICKSBURG (36C10G) | 621511 | MODIFICATION P1 TO ADD AN ADDITIONAL POC FOR FMI AND ADDITIONAL REPORT | $25M |
| Sep 26, 2025 | Department of Health and Human ServicesASPR/ORM-SNS | 325412 | PROCURENT OF XOFLUZA (BALOXAVIR MARBOXIL) 40MG AND 80MG TABLETS | $37M |
| Sep 26, 2025 | Department of DefenseDLA TROOP SUPPORT | 325412 | 4569634525!TNKASE 50 MG KITS | $21K → |
| Sep 11, 2025 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 541714 | THIS PROJECT FOCUSES ON ADDRESSING CRITICAL CHALLENGES IN THE DESIGN AND ANALYSIS OF HYBRID RANDOMIZED CONTROLLED TRIALS (RCTS) IN LONGITUDINAL SETTINGS. THE FIRST GOAL IS TO DEVELOP CAUSAL METHODOLOGIES FOR MANAGING DIVERSE MISSING DATA PATTERNS IN | $1.1M |
| Sep 4, 2025 | Department of DefenseDLA TROOP SUPPORT | 325412 | 4569386624!TAMIFLU 75 MG CAPSULE 10S | $1K |
| Aug 21, 2025 | Department of Veterans Affairs250-NETWORK CONTRACT OFFICE 10 (36C250) | 621511 | HEMATOLOGIC MALIGNANCY NEXT GENERATION SEQUENCING (NSG) EMERGENCY | $110K |
| Aug 20, 2025 | Department of Veterans AffairsSTRATEGIC ACQUISITION CENTER FREDERICKSBURG (36C10G) | 621511 | TASK ORDER FOR BASE YEAR | $7.8M |
| Aug 15, 2025 | Department of DefenseDLA TROOP SUPPORT | 325412 | 4569140669!TNKASE 50 MG KITS | $16K |
| Aug 7, 2025 | Department of Health and Human ServicesPHOENIX AREA INDIAN HEALTH SVC | 325413 | ROCHE DIABETES CARE, ROCHE DIABETES SUPPLIES, PIMC, MATERIALS MANAGEMENT | $250K |
| Jul 30, 2025 | Department of DefenseDLA TROOP SUPPORT | 325412 | 4568944488!TNKASE 50 MG KITS | $16K |
| Jun 16, 2025 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541714 | ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA | $5.6M |
| Jun 9, 2025 | Department of DefenseDLA TROOP SUPPORT | 325412 | 4568495914!TNKASE 50 MG KITS | $11K |
| May 14, 2025 | Department of DefenseDLA TROOP SUPPORT | 325412 | 8511378265!OTHER MEDICAL | $872K |
| May 5, 2025 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541714 | ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA | $12M |
| Apr 8, 2025 | Department of DefenseDLA TROOP SUPPORT | 325412 | 4567906643!TNKASE 50 MG KITS | $11K |
| Apr 1, 2025 | Department of DefenseDLA TROOP SUPPORT | 325412 | 4567906644!TNKASE 50 MG KITS | $5K |
| Mar 24, 2025 | Department of Health and Human ServicesNAVAJO AREA INDIAN HEALTH SVC | 325413 | FY 25 ROCHE DIABETES CARE BPA - MEDICAL SUPPLY | $102K |
Want to win work like Spark Therapeutics INC.?
Their contracts will eventually end — and when they do, the government has to award that work again. Mindy tells you up to a year early, so you can be ready to compete for it.